RSSS Form 4: Director converts 150,000 stock options into common shares

Rhea-AI Filing Summary

Research Solutions, Inc. (RSSS) director Form 4 reports an option exercise and share acquisition. On 11/17/2025, the reporting director exercised an option to purchase 150,000 shares of common stock at an exercise price of $0.70 per share, coded as transaction type "M" (option exercise). After this transaction, the director beneficially owned 318,500 shares of common stock directly and 75,000 shares indirectly through an IRA. A corresponding entry in the derivative table shows the option to purchase 150,000 shares at $0.70, originally exercisable on 12/04/2015 and expiring on 12/03/2025, with zero derivative securities remaining following this exercise.

Insider Trade Summary

150,000 shares exercised/converted

Mixed 3 txns

Insider Regazzi John J

Role Director

Type	Security	Shares	Price	Value
Exercise	Option to purchase common stock	150,000	$0.00	--
Exercise	Common Stock	150,000	$0.70	$105K
holding	Common Stock	--	--	--

Holdings After Transaction: Option to purchase common stock — 0 shares (Direct); Common Stock — 318,500 shares (Direct); Common Stock — 75,000 shares (Indirect, By IRA)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Regazzi John J

(Last) (First) (Middle)

C/O RESEARCH SOLUTIONS, INC.

(Street)

COLUMBIA SC 29201

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Research Solutions, Inc. [ RSSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/17/2025		M		150,000	A	$0.7	318,500	D
Common Stock								75,000	I	By IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase common stock	$0.7	11/17/2025		M			150,000	12/04/2015	12/03/2025	Common Stock	150,000	$0	0	D

Explanation of Responses:

	/s/ William Nurthen, Attorney-in-Fact	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Research Solutions (RSSS) report on this Form 4?

The Form 4 reports that a director of Research Solutions exercised an option to purchase 150,000 shares of common stock on 11/17/2025.

What was the exercise price of the options exercised by the RSSS director?

The director exercised an option to purchase common stock at an exercise price of $0.70 per share.

How many Research Solutions (RSSS) shares does the director own after the transaction?

Following the reported transaction, the director beneficially owned 318,500 shares directly and 75,000 shares indirectly through an IRA.

What was the derivative security involved in this RSSS Form 4 filing?

The derivative security was an option to purchase 150,000 shares of common stock at $0.70 per share, with an expiration date of 12/03/2025.

What does transaction code "M" mean in the RSSS Form 4?

Transaction code "M" indicates the exercise or conversion of a derivative security, in this case an option to purchase Research Solutions common stock.

Does the RSSS director have any derivative securities left after this option exercise?

The filing shows zero derivative securities beneficially owned following the reported option exercise of 150,000 shares.